CVE-2012-0313 json
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via a…
published 2012-01-24 14 y ago modified 2026-06-16 4 mo ago also EUVD-2012-0349
- cvss
- 4.3
- version 2.0, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 1.0%
- EPSS 1.0% chance of exploitation in 30 days, percentile 64%
- public exploits
- 0
- none known
Summary
Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed.
Exploit prediction
1.04% chance of exploitation in the next 30 days, higher than 64% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 2.0 | 4.3 | AV:N/AC:M/Au:N/C:N/I:P/A:N |
Classification
- Weakness
-
- CWE-79 Improper Neutralization of Input During Web Page Generation
References
-
glucose.jp
/release/19
vendor-advisory
-
jvn.jp
/en/jp/JVN65869891/index.html
third-party-advisory
-
jvndb.jvn.jp
/jvndb/JVNDB-2012-000008
third-party-advisory
Sources
- CVE List CVE-2012-0313
- NVD CVE-2012-0313
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.